Synthetic fibronectin peptides and ischemic brain injury after transient middle cerebral artery occlusion in rats

Kiyoyuki Yanaka, Paul J. Camarata, Stephen R. Spellman, James B. Mccarthy, Leo T. Furcht, Walter C. Low, Roberto Heros

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Leukocytes play an important role in the development of ischemia- reperfusion injury. This study was conducted to ascertain whether synthetic peptides corresponding to the cell- and heparin-binding sequences of fibronectin that disturb leukocyte adhesion molecules were effective in neuronal protection after transient focal cerebral ischemia in rats. The authors evaluated the efficacy of peptides on infarction size, leukocyte infiltration in the ischemic tissue, and neurological outcome in rats subjected to 1 hour of cerebral ischemia and 48 hours of reperfusion. Twenty- one animals were divided into three groups: transient ischemia without treatment (Group I), transient ischemia with administration of vehicle (Group II), and transient ischemia with administration of fibronectin peptides (Group III). The mean myeloperoxidase activity (U/g wet wt) in the ischemic area was as follows: Group I, 0.19% ± 0.05; Group II, 0.21% ± 0.03: and Group III, 0.08% ± 0.02. The mean size of the infarction as a percentage of the total hemispheric volume was as follows: Group I, 38.35% ± 1.34%; Group II, 39.21% ± 2.42%; and Group III, 25.81% ± 4.87%. Group III showed a significant decrease in myeloperoxidase activity in the lesion and the infarction size was smaller when compared to Groups I and II (p < 0.05). The neurological grade in Group III was significantly better than in Groups I and II at 48 hours after reperfusion (p < 0.01). This study is the first to explore the therapeutic potential of synthetic fibronectin peptides in brain protection after transient focal ischemia, and the results also serve as a basis for studies of important cellular and molecular events that contribute to tissue damage.

Original languageEnglish
Pages (from-to)125-130
Number of pages6
JournalJournal of Neurosurgery
Volume85
Issue number1
StatePublished - Jul 1 1996
Externally publishedYes

Fingerprint

Middle Cerebral Artery Infarction
Fibronectins
Brain Injuries
Ischemia
Infarction
Peptides
Peroxidase
Reperfusion
Leukocytes
Transient Ischemic Attack
Cell Adhesion Molecules
Reperfusion Injury
Brain Ischemia
Heparin
Brain
Therapeutics

Keywords

  • adhesion molecule
  • cerebral ischemia
  • leukocyte
  • rat

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)

Cite this

Yanaka, K., Camarata, P. J., Spellman, S. R., Mccarthy, J. B., Furcht, L. T., Low, W. C., & Heros, R. (1996). Synthetic fibronectin peptides and ischemic brain injury after transient middle cerebral artery occlusion in rats. Journal of Neurosurgery, 85(1), 125-130.

Synthetic fibronectin peptides and ischemic brain injury after transient middle cerebral artery occlusion in rats. / Yanaka, Kiyoyuki; Camarata, Paul J.; Spellman, Stephen R.; Mccarthy, James B.; Furcht, Leo T.; Low, Walter C.; Heros, Roberto.

In: Journal of Neurosurgery, Vol. 85, No. 1, 01.07.1996, p. 125-130.

Research output: Contribution to journalArticle

Yanaka, K, Camarata, PJ, Spellman, SR, Mccarthy, JB, Furcht, LT, Low, WC & Heros, R 1996, 'Synthetic fibronectin peptides and ischemic brain injury after transient middle cerebral artery occlusion in rats', Journal of Neurosurgery, vol. 85, no. 1, pp. 125-130.
Yanaka K, Camarata PJ, Spellman SR, Mccarthy JB, Furcht LT, Low WC et al. Synthetic fibronectin peptides and ischemic brain injury after transient middle cerebral artery occlusion in rats. Journal of Neurosurgery. 1996 Jul 1;85(1):125-130.
Yanaka, Kiyoyuki ; Camarata, Paul J. ; Spellman, Stephen R. ; Mccarthy, James B. ; Furcht, Leo T. ; Low, Walter C. ; Heros, Roberto. / Synthetic fibronectin peptides and ischemic brain injury after transient middle cerebral artery occlusion in rats. In: Journal of Neurosurgery. 1996 ; Vol. 85, No. 1. pp. 125-130.
@article{cbf8555c6d3448c5ab38bf4ab1092b97,
title = "Synthetic fibronectin peptides and ischemic brain injury after transient middle cerebral artery occlusion in rats",
abstract = "Leukocytes play an important role in the development of ischemia- reperfusion injury. This study was conducted to ascertain whether synthetic peptides corresponding to the cell- and heparin-binding sequences of fibronectin that disturb leukocyte adhesion molecules were effective in neuronal protection after transient focal cerebral ischemia in rats. The authors evaluated the efficacy of peptides on infarction size, leukocyte infiltration in the ischemic tissue, and neurological outcome in rats subjected to 1 hour of cerebral ischemia and 48 hours of reperfusion. Twenty- one animals were divided into three groups: transient ischemia without treatment (Group I), transient ischemia with administration of vehicle (Group II), and transient ischemia with administration of fibronectin peptides (Group III). The mean myeloperoxidase activity (U/g wet wt) in the ischemic area was as follows: Group I, 0.19{\%} ± 0.05; Group II, 0.21{\%} ± 0.03: and Group III, 0.08{\%} ± 0.02. The mean size of the infarction as a percentage of the total hemispheric volume was as follows: Group I, 38.35{\%} ± 1.34{\%}; Group II, 39.21{\%} ± 2.42{\%}; and Group III, 25.81{\%} ± 4.87{\%}. Group III showed a significant decrease in myeloperoxidase activity in the lesion and the infarction size was smaller when compared to Groups I and II (p < 0.05). The neurological grade in Group III was significantly better than in Groups I and II at 48 hours after reperfusion (p < 0.01). This study is the first to explore the therapeutic potential of synthetic fibronectin peptides in brain protection after transient focal ischemia, and the results also serve as a basis for studies of important cellular and molecular events that contribute to tissue damage.",
keywords = "adhesion molecule, cerebral ischemia, leukocyte, rat",
author = "Kiyoyuki Yanaka and Camarata, {Paul J.} and Spellman, {Stephen R.} and Mccarthy, {James B.} and Furcht, {Leo T.} and Low, {Walter C.} and Roberto Heros",
year = "1996",
month = "7",
day = "1",
language = "English",
volume = "85",
pages = "125--130",
journal = "Journal of Neurosurgery",
issn = "0022-3085",
publisher = "American Association of Neurological Surgeons",
number = "1",

}

TY - JOUR

T1 - Synthetic fibronectin peptides and ischemic brain injury after transient middle cerebral artery occlusion in rats

AU - Yanaka, Kiyoyuki

AU - Camarata, Paul J.

AU - Spellman, Stephen R.

AU - Mccarthy, James B.

AU - Furcht, Leo T.

AU - Low, Walter C.

AU - Heros, Roberto

PY - 1996/7/1

Y1 - 1996/7/1

N2 - Leukocytes play an important role in the development of ischemia- reperfusion injury. This study was conducted to ascertain whether synthetic peptides corresponding to the cell- and heparin-binding sequences of fibronectin that disturb leukocyte adhesion molecules were effective in neuronal protection after transient focal cerebral ischemia in rats. The authors evaluated the efficacy of peptides on infarction size, leukocyte infiltration in the ischemic tissue, and neurological outcome in rats subjected to 1 hour of cerebral ischemia and 48 hours of reperfusion. Twenty- one animals were divided into three groups: transient ischemia without treatment (Group I), transient ischemia with administration of vehicle (Group II), and transient ischemia with administration of fibronectin peptides (Group III). The mean myeloperoxidase activity (U/g wet wt) in the ischemic area was as follows: Group I, 0.19% ± 0.05; Group II, 0.21% ± 0.03: and Group III, 0.08% ± 0.02. The mean size of the infarction as a percentage of the total hemispheric volume was as follows: Group I, 38.35% ± 1.34%; Group II, 39.21% ± 2.42%; and Group III, 25.81% ± 4.87%. Group III showed a significant decrease in myeloperoxidase activity in the lesion and the infarction size was smaller when compared to Groups I and II (p < 0.05). The neurological grade in Group III was significantly better than in Groups I and II at 48 hours after reperfusion (p < 0.01). This study is the first to explore the therapeutic potential of synthetic fibronectin peptides in brain protection after transient focal ischemia, and the results also serve as a basis for studies of important cellular and molecular events that contribute to tissue damage.

AB - Leukocytes play an important role in the development of ischemia- reperfusion injury. This study was conducted to ascertain whether synthetic peptides corresponding to the cell- and heparin-binding sequences of fibronectin that disturb leukocyte adhesion molecules were effective in neuronal protection after transient focal cerebral ischemia in rats. The authors evaluated the efficacy of peptides on infarction size, leukocyte infiltration in the ischemic tissue, and neurological outcome in rats subjected to 1 hour of cerebral ischemia and 48 hours of reperfusion. Twenty- one animals were divided into three groups: transient ischemia without treatment (Group I), transient ischemia with administration of vehicle (Group II), and transient ischemia with administration of fibronectin peptides (Group III). The mean myeloperoxidase activity (U/g wet wt) in the ischemic area was as follows: Group I, 0.19% ± 0.05; Group II, 0.21% ± 0.03: and Group III, 0.08% ± 0.02. The mean size of the infarction as a percentage of the total hemispheric volume was as follows: Group I, 38.35% ± 1.34%; Group II, 39.21% ± 2.42%; and Group III, 25.81% ± 4.87%. Group III showed a significant decrease in myeloperoxidase activity in the lesion and the infarction size was smaller when compared to Groups I and II (p < 0.05). The neurological grade in Group III was significantly better than in Groups I and II at 48 hours after reperfusion (p < 0.01). This study is the first to explore the therapeutic potential of synthetic fibronectin peptides in brain protection after transient focal ischemia, and the results also serve as a basis for studies of important cellular and molecular events that contribute to tissue damage.

KW - adhesion molecule

KW - cerebral ischemia

KW - leukocyte

KW - rat

UR - http://www.scopus.com/inward/record.url?scp=0029992245&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029992245&partnerID=8YFLogxK

M3 - Article

VL - 85

SP - 125

EP - 130

JO - Journal of Neurosurgery

JF - Journal of Neurosurgery

SN - 0022-3085

IS - 1

ER -